Mrs. Dorit Miller, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2001 S Barrington Ave, #110, La, CA 90025 Phone: 310-485-1515 Fax: 310-477-4688 |
Dr. Patricia Lafferty, PH D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 10850 Wilshire Blvd Ste 740, La, CA 90024 Phone: 310-208-1151 Fax: 310-475-3955 |
Dr. Sharon Salfas, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 11911 San Vicente Blvd, Ste 240, La, CA 90049 Phone: 310-415-1539 Fax: 310-398-2603 |
Sheila Tsai Wu, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 520 So. Lafayette Park Place 3rd Floor, La, CA 90057 Phone: 213-252-2100 Fax: 213-383-3146 |
Nancy I Parson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5657 Wilshire Blvd, Suite 340, La, CA 90036 Phone: 323-931-3123 Fax: 323-938-4068 |
News Archive
Something must be done to protect the children of South Florida from this dangerous chemical says one student ready to bring the facts to the Broward County Commission. The government's recent announcement that the EPA is considering the addition of Bisphenol-A (BPA) to their list of "Chemicals of Concern," is a step in the right direction, but long overdue, according to high school junior and BPA researcher, Wendi Oppenheim.
SCIEX, a global leader in life science analytical technologies, and QPS Holdings, LLC (QPS), a leading global full-service Contract Research Organization (CRO), today announced a collaboration to advance Hybrid LBA –LCMS, a workflow for routine biologics quantification. Under the agreement, QPS Holdings will deploy the SCIEX BioBA Solution, the first end-to-end and most complete solution for bioanalysis of biologics.
We are disappointed by the passage of a House bill that we cannot support. The House legislation contains many provisions that will threaten the coverage that 177 million Americans currently have through the employer-based system. Not only does it establish a government-run health plan, but it includes a "play or pay" mandate for employers that would limit the flexibility employers have to develop innovative plans for our employees
Neuralstem, Inc. announced this morning that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
› Verified 7 days ago